Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.

Previous Article

UN Faces Big Budget Cuts And Job Losses After US Funding Dries Up

Next Article

‘I haven’t filed taxes in 20 years’: I’m 55 and about to get laid off. I’ve $1 million in crypto. Am I in big trouble?

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

+ 44 = 47
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨